BRIEF-Tempest Lays Out Strategic Plan To Advance Recently Acquired Dual-Targeting Car-T Assets

Tempest Therapeutics, Inc. -5.78% Pre

Tempest Therapeutics, Inc.

TPST

2.12

2.12

-5.78%

0.00% Pre

Feb 11 (Reuters) - Tempest Therapeutics Inc TPST.O:

  • TEMPEST LAYS OUT STRATEGIC PLAN TO ADVANCE RECENTLY ACQUIRED DUAL-TARGETING CAR-T ASSETS

  • TEMPEST THERAPEUTICS INC - PRIORITIZES TPST-2003 AND EXPANDS WITH TPST-4003

  • TEMPEST THERAPEUTICS INC - EXPECTS PHASE 2B INITIATION FOR TPST-2003 BY 2026 IN CHINA

  • TEMPEST THERAPEUTICS INC - TO INITIATE PHASE 2 STUDY OF TPST-1495 IN Q1 2026

  • TEMPEST THERAPEUTICS INC - PLANS TO PROGRESS ADDITIONAL DUAL TARGETING TPST-3003 CAR-T PROGRAM

Source text: ID:nGNX8ry0RW

Further company coverage: TPST.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.